Are PPIs Effective for Heartburn?
Yes, proton pump inhibitors (PPIs) are highly effective for treating heartburn and should be the first-line pharmacologic treatment for patients presenting with troublesome heartburn without alarm symptoms. 1
Initial Treatment Approach
For patients with heartburn, start with a 4- to 8-week trial of single-dose PPI therapy taken 30-60 minutes before a meal 1. This empiric approach is appropriate for patients without alarm symptoms (dysphagia, weight loss, bleeding, anemia). Any commercially available PPI can be used initially, with selection based on insurance coverage and cost 1.
Key Implementation Points:
- Timing matters: Take PPI 30-60 minutes before meals for optimal effect 1
- Reassess at 4-8 weeks to determine response 1
- Emphasize PPI safety to patients, as concerns about side effects often lead to non-adherence 1
If Initial Treatment Fails
When patients have inadequate response after 4-8 weeks:
- Increase to twice-daily dosing, OR
- Switch to a more potent PPI (rabeprazole, esomeprazole, or dexlansoprazole) 1
After another 4-8 weeks, if symptoms persist despite optimized PPI therapy, proceed to objective testing with endoscopy and pH monitoring to confirm GERD diagnosis 1.
Comparative Effectiveness
PPIs are superior to both H2-receptor antagonists and prokinetics for heartburn relief 2. In placebo-controlled trials:
- PPIs reduced heartburn by 63% (RR 0.37) in empiric treatment 2
- H2RAs reduced heartburn by only 23% (RR 0.77) 2
- PPIs were 34% more effective than H2RAs in direct comparisons (RR 0.66) 2
This superiority holds true even in patients with endoscopy-negative reflux disease, though the magnitude of benefit is somewhat smaller 2.
Long-Term Management
Once symptoms are controlled, taper PPIs to the lowest effective dose 1. This may include:
- Reducing from twice-daily to once-daily dosing
- Converting to on-demand therapy for patients who can successfully wean
- Discontinuing in patients who achieve sustained remission
Important Caveat:
Patients with erosive esophagitis (LA Grade B or higher) or Barrett's esophagus should remain on maintenance PPI therapy and should not be weaned 1.
When PPIs Don't Work
Up to 50% of patients with suspected GERD may not respond adequately to PPIs 1, 3. The most common reason is not actually having acid-related disease 3. In one study, 75% of PPI non-responders had low esophageal acid exposure, indicating esophageal hyperalgesia or a non-acid cause 3.
For PPI non-responders:
- Verify compliance and proper timing of medication
- Perform endoscopy to look for erosive disease
- Consider prolonged pH monitoring off PPI (96-hour preferred) to confirm or rule out GERD 1
- If GERD is ruled out, consider neuromodulation or behavioral therapy for functional heartburn 1
Special Considerations
For nocturnal heartburn specifically, PPIs effectively improve nighttime symptoms and associated sleep disturbances 4. The evidence consistently shows benefit for reflux-driven nocturnal symptoms, with improvements in both symptom relief and sleep quality.
Avoid empiric PPI trials in patients with isolated extra-esophageal symptoms (chronic cough, hoarseness) without typical heartburn—these patients should undergo objective testing first 1.